Science & Enterprise featured Quantitative Insights, Inc., a company founded and now advised by ITM investigator Maryellen Giger, PhD. The company created the industry’s first computer-aided diagnosis platform incorporating machine learning for evaluating breast abnormalities. The algorithm can help radiologists better diagnose breast cancer, and was recently cleared by the U.S. Food and Drug Administration (FDA).
The algorithm software, called QuantX, evaluates patients’ MRIs and medical data in comparison to a database of abnormalities and clinical pathology findings. The resulting QI score can inform the doctor’s diagnosis and improve diagnostic turnaround times, so your cancer can be detected faster and more accurately.
“Quantitative Insights has demonstrated that they can successfully take meaningful clinical innovations from research labs and clinics, develop them into products, take them through the regulatory process, and to the market.”
– Maryellen Giger, PhD, A.N. Pritzker Professor of Radiology and the College Vice-Chair for Basic Science Research.
Source: Science & Enterprise